A biologics client needed to reach the market quickly on a fast-track candidate. Working together, we built a risk-based CMC plan and engaged the FDA early to align on the approach before it became a barrier.
Impact for the client:
- Fast-track designation granted
- Early FDA alignment secured on the CMC approach
- Streamlined CMC package accepted
- Approval achieved in only six months
